PENTIXAPHARM
PentixaPharm GmbH, a joint venture of Scintomics GmbH and 1717 Life Science Ventures GmbH, is committed to develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair, specifically targeting the CXCR4-receptor expressed in most fast progressing diseases, particularly malignant cancers. Funding is dedicated for a phase II trial of the imaging compound PentixaFor and for a phase I trial of the therapeutic compound PentixaTher in Central Nervous System (CNS) Lymphoma while supporting proof-of-concept studies in various other indications.
PENTIXAPHARM
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2019-01-01
Address:
Würzburg, Bayern, Germany
Country:
Germany
Website Url:
http://www.pentixapharm.com
Total Employee:
1+
Status:
Active
Total Funding:
15 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network JsDelivr Dynatrace
Similar Organizations
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Current Employees Featured
Founder
Investors List
Eckert Life Science Accelerator
Eckert Life Science Accelerator investment in Series A - Pentixapharm
Official Site Inspections
http://www.pentixapharm.com Semrush global rank: 5.2 M Semrush visits lastest month: 1.56 K
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Pentixapharm"
About Us - Pentixapharm
Pentixapharm is a clinical-stage radiopharmaceutical development company founded in 2019 with its offices in Berlin and Würzburg, Germany. It is committed to developing CXCR4 ligand-based first-in-class radiopharmaceutical …See details»
Org Chart Pentixapharm - The Official Board
Organizational Chart of Pentixapharm. Pentixapharm www.pentixapharm.com. has 3 executives - and belongs to Eckert & Ziegler +49 931 9913 6076; Add an executive. Pentixapharm News . …See details»
Pentixapharm - Crunchbase Company Profile & Funding
PentixaPharm GmbH, a joint venture of Scintomics GmbH and 1717 Life Science Ventures GmbH, is committed to develop PentixaFor and PentixaTher as a …See details»
Reports — Pentixapharm
Annual Report, Pentixapharm Holding AG - (English / German) Consolidated Financial Statement, Pentixapharm Holding AG . Financial Statement, Pentixapharm Holding AG . Interim Report …See details»
Investors — Pentixapharm
Pentixapharm AG, a former subsidiary of Eckert & Ziegler Group, has successfully completed its spin-off into Pentixapharm Holding AG, followed by its listing on October 3, 2024, in the Prime Standard of the Frankfurt Stock …See details»
Pentixapharm AG, Financial Info, Board and Management, …
Changes In Board and Management in last 6 months: Men: 7 Women: 3 GENDER BALANCESee details»
Pentixapharm Holding AG Company Description - Stock Analysis
23 hours ago Pentixapharm Holding AG was founded in 2019 and is based in Berlin, Germany. Pentixapharm Holding AG. Country: Germany: Founded: 2019: Industry: In Vitro and In Vivo …See details»
PentixaPharm - Overview, News & Similar companies - ZoomInfo
Who is PentixaPharm. PentixaPharm, founded in 2019, is a radiopharmaceutical development company committed to developing the innovative theranostic pair PentixaFor and PentixaTher. …See details»
Pentixapharm AG - Company Profile and News - Bloomberg Markets
Pentixapharm AG is a clinical-stage radiopharmaceutical development company. The Company focuses on developing CXCR4 ligand-based radiopharmaceutical approaches for diagnostic …See details»
Pentixapharm - M&A Summary and Business Overview | Mergr
Pentixapharm is a radiopharmaceutical company developing CXCR4 ligand-based first-in-class radiopharmaceutical approaches with a clear commercial pathway for diagnostic and …See details»
Pentixapharm (Pentixapharm GmbH) - Startbase
Jobs at Pentixapharm: Other Startups nearby. snapADDY. Startup 2015 Würzburg. snapADDY. Business card scanner app. BOTfriends. Startup 2017 Würzburg. BOTfriends. Software to …See details»
Pentixapharm AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Pentixapharm AG of Berlin, Berlin. Get the latest business insights from Dun & Bradstreet.See details»
Pentixapharm AG - Würzburg, Germany - bionity.com
Jul 16, 2024 Pentixapharm is a radiopharmaceutical development company founded in 2019, with its headquarters in Würzburg, Germany. Its clinical pipeline encompasses PentixaTher, …See details»
Pentixapharm - VentureRadar
PentixaPharm is committed to developing the innovative theranostic pair PentixaFor and PentixaTher. PentixaFor and PentixaTher are two-small peptide-based radiopharmaceuticals …See details»
PentixaPharm GmbH - Drug pipelines, Patents, Clinical trials
Explore PentixaPharm GmbH with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 6 news, and 2 literature, Disease Domain:Neoplasms, Hemic and Lymphatic Diseases, Immune System Diseases, Endocrinology and Metabolic Disease, Technology Platform:Monoclonal antibody, Diagnostic radiopharmaceuticals, Small molecule drug, Peptide …See details»
Pentixapharm Holding 2025 Company Profile: Stock ... - PitchBook
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases.See details»
Pentixapharm | EU-Startups
PentixaPharm GmbH, a joint venture of Scintomics GmbH and 1717 Life Science Ventures GmbH, is committed to develop PentixaFor and PentixaTher as a theranostic …See details»
Pentixapharm: the radiopharmaceutical company with a head start …
Sep 5, 2024 Amid a surge in radiopharmaceutical investments, Pentixapharm, a subsidiary of Eckert & Ziegler Group, is set to spin off as an independent company listed on the Frankfurt …See details»
Pentixapharm Holding AG Releases Financial Results for 2024 and ...
BERLIN - April 15, 2025 (NEWMEDIAWIRE) - The Management Board and Supervisory Board of Pentixapharm Holding AG today announced the following key resolutions: The Group closed the 2024 financial ...See details»
Eckert & Ziegler Signs Contract Manufacturing Agreement for …
Apr 24, 2025 About Pentixapharm Pentixapharm is a clinical-stage biotech company discovering and developing novel targeted radiopharmaceuticals with offices in Berlin and Würzburg, …See details»